icd10free.comPowered by Curo
D45BillableSave

D45 - Polycythemia vera

ICD-10-CM Chapter 2: Neoplasms · D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48) · Top-level category · FY2027

Includes, Excludes and Coding Notes

Excludes 1 — Not Coded HereFrom D45

Mutually exclusive: these conditions are never reported together with this code.

  • familial polycythemia (D75.0)
  • secondary polycythemia (D75.1)
Excludes 1 — Not Coded HereFrom D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Mutually exclusive: these conditions are never reported together with this code.

  • neoplasms of unspecified behavior (D49.-)
NotesFrom D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Instructional notes from the ICD-10-CM tabular list.

  • Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
NotesFrom Chapter C00-D49

Instructional notes from the ICD-10-CM tabular list.

  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

Inpatient DRG Payments

DRG 8408,191 discharges

Lymphoma And Non-acute Leukemia With Mcc

Avg. Medicare Payment

$28,324

Total Payment$34,735
Patient Responsibility$6,411
Hospital Charge$155,957
DRG 8415,419 discharges

Lymphoma And Non-acute Leukemia With Cc

Avg. Medicare Payment

$13,121

Total Payment$16,550
Patient Responsibility$3,429
Hospital Charge$83,307
DRG 8232,474 discharges

Lymphoma And Non-acute Leukemia With Other Procedures With Mcc

Avg. Medicare Payment

$42,242

Total Payment$49,976
Patient Responsibility$7,734
Hospital Charge$245,686
DRG 8241,887 discharges

Lymphoma And Non-acute Leukemia With Other Procedures With Cc

Avg. Medicare Payment

$18,489

Total Payment$23,946
Patient Responsibility$5,457
Hospital Charge$122,441
DRG 821890 discharges

Lymphoma And Leukemia With Major O.r. Procedures With Cc

Avg. Medicare Payment

$20,009

Total Payment$24,281
Patient Responsibility$4,272
Hospital Charge$121,353
DRG 822661 discharges

Lymphoma And Leukemia With Major O.r. Procedures Without Cc/mcc

Avg. Medicare Payment

$9,616

Total Payment$13,057
Patient Responsibility$3,442
Hospital Charge$74,038
DRG 8201,068 discharges

Lymphoma And Leukemia With Major O.r. Procedures With Mcc

Avg. Medicare Payment

$58,507

Total Payment$70,733
Patient Responsibility$12,226
Hospital Charge$320,318
DRG 842760 discharges

Lymphoma And Non-acute Leukemia Without Cc/mcc

Avg. Medicare Payment

$8,075

Total Payment$11,312
Patient Responsibility$3,237
Hospital Charge$53,076

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with D45.